Seoul, South Korea

Jin Wan Kim

This inventor holds 1 USPTO granted patent. Top assignee: Cj Corporation. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin Wan Kim. Retrieved from https://idiyas.com/inventor/jin-wan-kim-j7aupcp3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jin Wan Kim: Innovator in Pharmaceutical Chemistry

Introduction

Jin Wan Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative methods in drug preparation. His work exemplifies the intersection of creativity and scientific rigor.

Latest Patents

Jin Wan Kim holds a patent for a method of preparing oltipraz. This method involves the reaction of methyl 2-methyl-3-(pyrazin-2-yl)-3-oxopropionate with phosphorus pentasulfide in a mixed solvent of toluene and xylene, followed by recrystallization. This innovative approach enhances the efficiency of producing this important pharmaceutical compound.

Career Highlights

Throughout his career, Jin Wan Kim has been associated with Cj Corporation, a leading company in the pharmaceutical industry. His expertise and innovative methods have contributed to the advancement of drug development processes within the organization.

Collaborations

Jin Wan Kim has worked alongside talented colleagues such as Kwang Do Choi and Jee Woong Lim. Their collaborative efforts have fostered a productive environment for innovation and research.

Conclusion

Jin Wan Kim's contributions to pharmaceutical chemistry through his patent for preparing oltipraz highlight his role as an influential inventor. His work continues to impact the field positively, showcasing the importance of innovation in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…